Dubai. Akhbar-Alkhaleej
"Pioneer," the Iraqi pharmaceutical company, enters the UAE market with 43 life-saving drug varieties in partnership with UAE-based Life Pharma. The announcement, made at the Dubai International Pharmaceutical and Technology Exhibition (DUPHAT 2024), reveals plans to produce 150 new pharmaceutical products this year, adding to the current 250
Dr. Abdul Salam Soudah, Pioneer's Director of Foreign Markets and Export, emphasized the strategic significance of entering the growing UAE pharmaceutical market, citing the ease of procedures and market size
The focus this year includes registering drugs for reflux in cancer patients and diabetes treatment. Life Pharma's CEO, Dr. Magdy Fahmy, anticipates marketing 20 agreed-upon drugs this year, with the first batch targeting stomach conditions, pain relief, antibiotics, and reflux in children. Life Pharma will handle packaging, quality control, and distribution, fostering a long-term strategic collaboration in the pharmaceutical sector